BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 14,220
+400 (2.89%)
Nov 20, 2025, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 440.13 billion as of November 20, 2025. Its market cap has decreased by -35.42% in one year.
Market Cap
440.13B
Enterprise Value
510.86B
Revenue
153.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,220.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 440.13B, an increase of 1,640.63%. That is a compound annual growth rate of 12.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 440.13B | -24.65% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | 828.30B | 236.18% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.78T |
| ALTEOGEN | 29.09T |
| SK Biopharmaceuticals | 9.84T |
| ABL Bio | 9.37T |
| Yuhan | 8.68T |
| Peptron | 7.80T |
| LigaChem Biosciences | 6.31T |